1. Aggeler, P.M., O'Reilly, R.: Effect of heptabarbital on the response to bishydroxycoumarin in man. J. Lab. clin. Med.74, 229?238 (1969)
2. Atkinson, R.M., Bedford, C.B., Child, K.J., Tomich, E.G.: Effect of particle size on blood griseofulvin levels in man. Nature (Lond.)193, 588?590 (1962)
3. Balasubramaniam, K., Lucas, S.B., Mawer, G.E., Simons, P.J.: The kinetics of amylobarbitone metabolism in healthy men and women. Brit. J. Pharmacol.39, 564?572 (1970)
4. Barr, W.H.: Bioavailability of oral solid dosage forms and clinical response to drug therapy. In: Current concepts in the pharmaceutical sciences: dosage form design and bioavailability. Philadelphia: Lea & Febiger 1973
5. Benet, L.Z.: Biopharmaceutics as a basis for the design of drug products. In: Drug design, Vol. IV. New York: Academic Press 1973